Metabolic Disease Gene Therapy Program

About BioGene Therapeutics

BioGene Therapeutics is a US-based biotech firm focused on developing advanced gene therapies and delivery platforms for metabolic diseases, primarily diabetes and obesity. Its core technology is a proprietary bioresponsive lipid nanoparticle (bLNP) system designed for precision delivery of genetic medicines. The company appears to be in the pre-clinical or early clinical stage, is publicly traded, and is building a leadership team with expertise in metabolic research and technology development. Its strategy centers on transforming the treatment landscape for widespread metabolic disorders through targeted gene-based interventions.

Therapeutic Areas

Other Diabetes and Obesity Drugs